Deden A C, Alma M A, Van Zelst-Stam W A G
Radboudumc, afd. Genetica, Nijmegen en UMCG, afd. Genetica, Groningen.
UMCG/RUG, afd. Toegepast Gezondheidsonderzoek, Groningen.
Ned Tijdschr Geneeskd. 2020 Apr 30;164:D4157.
According to the European definition, rare diseases are life-threatening or chronically debilitating conditions that affect only 5 out of 10,000 people in the European Union. It is estimated that there are around 6000-8000 different rare diseases, affecting 6-8% of the population in the course of their lives. For the Netherlands, this means that about 1 million people are affected by a rare disease, or one in 17 people. Patients with rare diseases indicate that they often have a long and uncertain diagnostic journey behind them, while the first symptoms present in childhood in 75% of the rare diseases. In this perspective, we discuss some of the results from the research report 'Scherperzicht op diagnostischevertragingbijzeldzameaandoeningen' in which the diagnostic journey for patients with rare diseases is mapped out with figures. We also make recommendations to speed up the diagnostic process for patients with rare diseases.
根据欧洲的定义,罕见病是指那些危及生命或导致长期衰弱的疾病,在欧盟每万人中仅有5人受其影响。据估计,大约有6000 - 8000种不同的罕见病,一生中会影响6% - 8%的人口。对荷兰而言,这意味着约100万人受罕见病影响,即每17人中就有1人患病。罕见病患者表示,他们往往经历漫长且不确定的诊断过程,而75%的罕见病在儿童期就会出现最初症状。从这个角度出发,我们将讨论研究报告《聚焦罕见病诊断延迟》中的一些结果,该报告用数据描绘了罕见病患者的诊断过程。我们还将提出加快罕见病患者诊断进程的建议。